Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

HC Wainwright & Co. Maintains Buy on Lipocine, Raises Price Target to $3.5

HC Wainwright & Co. analyst Oren Livnat maintains Lipocine (NASDAQ:LPCN) with a Buy and raises the price target from $2.5 to $3.5.
byBenzinga Newsdesk
August 26, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

HC Wainwright & Co. analyst Oren Livnat maintains Lipocine (NASDAQ:LPCN) with a Buy and raises the price target from $2.5 to $3.5.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0